Dulera and Injection site erythema - a phase IV clinical study of FDA data

Summary:

Injection site erythema is reported as a side effect among people who take Dulera (mometasone furoate; formoterol fumarate), especially for people who are female, 40-49 old, also take Humira, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Injection site erythema when taking Dulera. It is created by eHealthMe based on reports of 4,533 people who have side effects when taking Dulera from the FDA, and is updated regularly.

What is Dulera?

Dulera has active ingredients of mometasone furoate; formoterol fumarate. It is often used in asthma. eHealthMe is studying from 4,801 Dulera users. Check the latest studies of Dulera.

What is Injection site erythema?

Injection site erythema (redness at injection site) is found to be associated with 1,449 drugs and 1,417 conditions by eHealthMe. Check the latest studies of Injection site erythema.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

4,533 people reported to have side effects when taking Dulera.
Among them, 13 people (0.29%) have Injection site erythema.

Could Dulera cause Injection site erythema?

Among these 13 people:

What is the gender of people who have Injection site erythema when taking Dulera? *

female: 92.31 %
male: 7.69 %

What is the age of people who have Injection site erythema when taking Dulera? *

What are other drugs people take besides Dulera? *

What are other side effects people have besides Injection site erythema? *

Injection Site Swelling: 4 people, 30.77%
Injection Site Warmth: 3 people, 23.08%
Headache (pain in head): 3 people, 23.08%
Cellulitis (infection under the skin): 3 people, 23.08%
Injection Site Reaction: 3 people, 23.08%
Rashes (redness): 3 people, 23.08%
Dyspnea (difficult or laboured breathing): 3 people, 23.08%
Injection Site Pruritus (severe itching at injection site): 3 people, 23.08%
Nausea (feeling of having an urge to vomit): 3 people, 23.08%
Diarrhea: 2 people, 15.38%

What are the existing conditions these people have? *

Pain: 4 people, 30.77%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 30.77%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 30.77%
Hypersensitivity: 3 people, 23.08%
High Blood Cholesterol: 3 people, 23.08%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 23.08%
Stress And Anxiety: 2 people, 15.38%
Depression: 2 people, 15.38%
Diabetes: 2 people, 15.38%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Dulera and have Injection site erythema?

- Check whether Injection site erythema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dulera:

Dulera (4,801 reports)

Injection site erythema treatments and more:

Injection site erythema (120,311 reports)

How severe was Injection site erythema and when was it recovered:

Injection site erythema in Dulera

Expand to all the drugs that have ingredients of mometasone furoate; formoterol fumarate:

Injection site erythema and drugs with ingredients of mometasone furoate; formoterol fumarate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dulera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Injection site erythema:

Injection site erythema (1,449 drugs)

Browse all the conditions that are associated with Injection site erythema:

Injection site erythema (1,417 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mometasone furoate; formoterol fumarate (the active ingredients of Dulera) and Dulera (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.